NCT05151380View on ClinicalTrials.gov

Clinical and Cyto-histological Evaluation of Fractional CO2 Laser Treatment on Genito-Urinary Syndromes of Menopause Related to Vaginal Atrophy

NACompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

September 11, 2023

Study Completion Date

November 10, 2023

Conditions
Genitourinary Syndrome of Menopause
Interventions
DEVICE

CO2 laser MonaLisa Touch ®

"3 sessions of SmartXide fractional CO2 laser via the MonaLisa Touch® device, spaced 4 weeks apart, will be performed. An additional comfort session will be performed at 1 year if needed.~The handpiece of the MonaLisa Touch® device is applied to the vaginal walls with a 360° scan, between 800 and 1100µs, to the vaginal orifice"

Trial Locations (1)

90400

Hôpital Nord Franche-Comté, Trévenans

All Listed Sponsors
lead

Hopital Nord Franche-Comte

OTHER

NCT05151380 - Clinical and Cyto-histological Evaluation of Fractional CO2 Laser Treatment on Genito-Urinary Syndromes of Menopause Related to Vaginal Atrophy | Biotech Hunter | Biotech Hunter